GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (OTCPK:MAYNF) » Definitions » Net Margin %

Mayne Pharma Group (Mayne Pharma Group) Net Margin % : -37.69% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Mayne Pharma Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Mayne Pharma Group's Net Income for the six months ended in Dec. 2023 was $-47.2 Mil. Mayne Pharma Group's Revenue for the six months ended in Dec. 2023 was $125.3 Mil. Therefore, Mayne Pharma Group's net margin for the quarter that ended in Dec. 2023 was -37.69%.

The historical rank and industry rank for Mayne Pharma Group's Net Margin % or its related term are showing as below:

MAYNF' s Net Margin % Range Over the Past 10 Years
Min: -90.47   Med: -7.4   Max: 64.28
Current: -90.47


MAYNF's Net Margin % is ranked worse than
84.33% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.06 vs MAYNF: -90.47

Mayne Pharma Group Net Margin % Historical Data

The historical data trend for Mayne Pharma Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Net Margin % Chart

Mayne Pharma Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.60 -20.32 -52.06 -62.12 64.29

Mayne Pharma Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.68 -93.51 288.18 -211.34 -37.69

Competitive Comparison of Mayne Pharma Group's Net Margin %

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mayne Pharma Group's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Net Margin % falls into.



Mayne Pharma Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Mayne Pharma Group's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=78.691/122.409
=64.29 %

Mayne Pharma Group's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-47.224/125.297
=-37.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mayne Pharma Group  (OTCPK:MAYNF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Mayne Pharma Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mayne Pharma Group (Mayne Pharma Group) Business Description

Traded in Other Exchanges
Address
1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.